Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Achieving the goals of effective, safe, and individualized cancer care.

Roberts SA, Karnes EK, Allen JD, Benner JS, Sigal EV, McClellan M.

Clin Cancer Res. 2011 Nov 1;17(21):6632-3. doi: 10.1158/1078-0432.CCR-11-1104. No abstract available.

PMID:
22046023
[PubMed - indexed for MEDLINE]
Free Article
2.

Cancer biomarkers. Preface.

Dixit R, Srivastava S.

Cancer Biomark. 2005;1(1):3-4. No abstract available.

PMID:
17203571
[PubMed - indexed for MEDLINE]
3.

Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeutics.

Scher HI, Nasso SF, Rubin EH, Simon R.

Clin Cancer Res. 2011 Nov 1;17(21):6634-40. doi: 10.1158/1078-0432.CCR-11-1105.

PMID:
22046024
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Time to adapt.

[No authors listed]

Nature. 2010 Apr 29;464(7293):1245-6. doi: 10.1038/4641245b. No abstract available.

PMID:
20428115
[PubMed - indexed for MEDLINE]
5.

[Methodological approaches of clinical studies with targeted therapies].

Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J.

Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Review. French.

PMID:
18304903
[PubMed - indexed for MEDLINE]
6.

Assessing cancer pain.

Dalal S, Bruera E.

Curr Pain Headache Rep. 2012 Aug;16(4):314-24. doi: 10.1007/s11916-012-0274-y. Review.

PMID:
22585314
[PubMed - indexed for MEDLINE]
7.

Future of personalized medicine in oncology: a systems biology approach.

Gonzalez-Angulo AM, Hennessy BT, Mills GB.

J Clin Oncol. 2010 Jun 1;28(16):2777-83. doi: 10.1200/JCO.2009.27.0777. Epub 2010 Apr 20. Review.

PMID:
20406928
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical trial designs for targeted agents.

Ma BB, Britten CD, Siu LL.

Hematol Oncol Clin North Am. 2002 Oct;16(5):1287-305. Review.

PMID:
12512393
[PubMed - indexed for MEDLINE]
9.

Integrating pain metrics into oncology clinical trials.

Cleeland CS, O'Mara A, Zagari M, Baas C.

Clin Cancer Res. 2011 Nov 1;17(21):6646-50. doi: 10.1158/1078-0432.CCR-11-1109.

PMID:
22046026
[PubMed - indexed for MEDLINE]
Free Article
10.

Biomarker-driven patient selection for early clinical trials.

Dienstmann R, Rodon J, Tabernero J.

Curr Opin Oncol. 2013 May;25(3):305-12. doi: 10.1097/CCO.0b013e32835ff3cb. Review.

PMID:
23493192
[PubMed - indexed for MEDLINE]
11.

Cancer-related forecast biomarkers: a topic in focus of the Worldwide Innovative Network in Personalized Cancer Medicine (WIN).

Schmitt M, Lazar V.

Bioanalysis. 2010 May;2(5):851-3. doi: 10.4155/bio.10.47. No abstract available.

PMID:
21083216
[PubMed - indexed for MEDLINE]
Free Article
12.

Advances and challenges in the use of biomarkers in clinical trials.

Chabner B.

Clin Adv Hematol Oncol. 2008 Jan;6(1):42-3. Review. No abstract available.

PMID:
18322440
[PubMed - indexed for MEDLINE]
13.

Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.

Parkinson DR, Johnson BE, Sledge GW.

Clin Cancer Res. 2012 Feb 1;18(3):619-24. doi: 10.1158/1078-0432.CCR-11-2017.

PMID:
22298894
[PubMed - indexed for MEDLINE]
Free Article
14.

Biological markers: Tailoring treatment and trials to prognosis.

Kerr DJ, Shi Y.

Nat Rev Clin Oncol. 2013 Aug;10(8):429-30. doi: 10.1038/nrclinonc.2013.97. Epub 2013 Jun 11. No abstract available.

PMID:
23752731
[PubMed - indexed for MEDLINE]
15.

Cancer biomarkers: selecting the right drug for the right patient.

Kelloff GJ, Sigman CC.

Nat Rev Drug Discov. 2012 Feb 10;11(3):201-14. doi: 10.1038/nrd3651. Review.

PMID:
22322254
[PubMed - indexed for MEDLINE]
16.

The value of acupuncture in cancer care.

Lu W, Dean-Clower E, Doherty-Gilman A, Rosenthal DS.

Hematol Oncol Clin North Am. 2008 Aug;22(4):631-48, viii. doi: 10.1016/j.hoc.2008.04.005. Review.

PMID:
18638692
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments.

Galanis E, Wu W, Sarkaria J, Chang SM, Colman H, Sargent D, Reardon DA.

Curr Oncol Rep. 2011 Feb;13(1):42-9. doi: 10.1007/s11912-010-0144-x. Review.

PMID:
21125354
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Oncology trials gear up for high-throughput sequencing.

Mullard A.

Nat Rev Drug Discov. 2012 Apr 30;11(5):339-40. doi: 10.1038/nrd3733. No abstract available.

PMID:
22543457
[PubMed - indexed for MEDLINE]
19.

Clinical trial methods to discover and validate predictive markers for treatment response in cancer.

Paik S.

Biotechnol Annu Rev. 2003;9:259-67. Review.

PMID:
14650930
[PubMed - indexed for MEDLINE]
20.

WIN Consortium--challenges and advances.

Mendelsohn J, Tursz T, Schilsky RL, Lazar V.

Nat Rev Clin Oncol. 2011 Mar;8(3):133-4. doi: 10.1038/nrclinonc.2010.230. No abstract available.

PMID:
21364685
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk